(lp0
S"Infinity Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 17 Equities.com - 17 hours ago Infinity Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock gained 9.23% to close at $3.55.Infinity Pharmaceuticals Inc.  Forecasted to Post FY2019 Earnings of ($0 ... - Chaffey BreezeWilliam Blair Weighs in on Infinity Pharmaceuticals Inc.'s Q1 2017 Earnings  - The Cerbat Gem"
p1
aS"Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today Motley Fool - Jun 14, 2016 So what: Infinity Pharmaceuticals released data from its phase 2 monotherapy study of duvelisib, the company's investigational compound being researched as a possible treatment for non-Hodgkin lymphoma.Infinity Pharmaceuticals' Disappointing Data - Barron'sInfinity Pharma At Risk Of AbbVie 'Walking Away' - Benzinga"
p2
aS'Infinity Announces Organizational Changes PR Newswire  - Jan 4, 2017 CAMBRIDGE, Mass., Jan. 4, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  today announced that Lawrence Bloch, M.D.Infinity Pharma R&amp;D Chief Adams Retires Amid Restructuring, Job Cuts - Xconomy'
p3
aS'Infinity Pharma Surges On Latest Cancer Drug Hope Seeking Alpha - Jan 25, 2017 Infinity Pharma  has seen its stock price shoot up in recent days due to promising preclinical data on its IPI-549 cancer drug.'
p4
aS'Infinity Pharmaceuticals  Catches Eye: Stock Up 13.5% Yahoo Finance - Mar 1, 2017 Infinity Pharmaceuticals, Inc. INFI was a big mover last session, as the company saw its shares rise almost 7% on the day.Infinity Pharmaceuticals Inc.  Plunges 5.65% on March 03 - Equities.comWhy did Infinity Pharmaceuticals, Inc.  Gain +20%? - StockNewsUnion'
p5
aS'Infinity Pharma cuts 100 jobs after AbbVie deal is terminated The Boston Globe - Jun 28, 2016 Infinity Pharmaceuticals Inc. said Tuesday it will cut 100 jobs and give retention bonuses to remaining employees - including a total of almost $1 million to four top executives - in a bid to continue developing its experimental treatment for blood ...Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With ... - PR Newswire AbbVie scraps Infinity collab in wake of weak data; biotech slashes jobs - FierceBiotech'
p6
aS"Infinity Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at ... PR Newswire  - Jan 20, 2017 CAMBRIDGE, Mass., Jan. 20, 2017 /PRNewswire/ -- Today, during a plenary session at the Keystone Symposia Conference, &quot;PI3K Pathways in Immunology, Growth Disorders and Cancer,&quot; Infinity Pharmaceuticals, Inc.  presented preclinical&nbsp;...Infinity Pharma's lead product candidate IPI-549 shows encouraging results in ... - Seeking Alpha"
p7
aS'Infinity to Present at 37th Annual Cowen and Company Healthcare Conference PR Newswire  - Feb 27, 2017 CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  will be presenting at the Cowen and Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of&nbsp;...'
p8
aS'Infinity Announces Promotion of Jeffery Kutok, MD, Ph.D. to Chief Scientific ... PR Newswire  - Feb 13, 2017 CAMBRIDGE, Mass., Feb. 13, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  today announced that Jeffery Kutok, M.D.Infinity Pharmaceuticals  Stock: Up Big On Management Announcement - CNA Finance '
p9
aS"Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At ... PR Newswire  - Sep 26, 2016 CAMBRIDGE, Mass., Sept. 26, 2016 /PRNewswire/ -- Infinity Pharmaceuticals, Inc.  today announced initial clinical and new preclinical data for IPI-549, an orally administered immuno-oncology development candidate that selectively inhibits&nbsp;...Company Update : Infinity Pharmaceuticals Inc. Presents Initial ... - Smarter AnalystInfinity Pharmaceuticals  Stock Rises on 'Favorable' Cancer Drug Trial ... - TheStreet.com"
p10
a.